These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9704177)

  • 21. Pathology of nasopharyngeal carcinoma. Proposal of a new histologic classification correlated with prognosis.
    Hsu HC; Chen CL; Hsu MM; Lynn TC; Tu SM; Huang SC
    Cancer; 1987 Mar; 59(5):945-51. PubMed ID: 3028595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of clinic biopsy specimens in classifying histopathologic characteristics of recurrent nasopharyngeal carcinoma.
    Brown JJ; Berry GJ; Moretto J; Keating WF; Fee WE
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):950-5. PubMed ID: 9305245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoma of female urethra. Manitoba experience: 1958-1987.
    Hahn P; Krepart G; Malaker K
    Urology; 1991 Feb; 37(2):106-9. PubMed ID: 1992577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical and flow cytometric analysis of patients with nasopharyngeal cancer.
    Costello F; Mason BR; Collins RJ; Kearsley JH
    Cancer; 1990 Oct; 66(8):1789-95. PubMed ID: 2208035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
    Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
    Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
    Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma.
    Chen CL; Hsu MM
    Hum Pathol; 2000 Feb; 31(2):227-32. PubMed ID: 10685638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.
    Chan AT; Lo YM; Zee B; Chan LY; Ma BB; Leung SF; Mo F; Lai M; Ho S; Huang DP; Johnson PJ
    J Natl Cancer Inst; 2002 Nov; 94(21):1614-9. PubMed ID: 12419787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity.
    Lee AW; Sze WM; Yau TK; Yeung RM; Chappell R; Fowler JF
    Radiother Oncol; 2001 Feb; 58(2):121-30. PubMed ID: 11166862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma--a retrospective review of 182 cases.
    Yang TS; Ng KT; Wang HM; Wang CH; Liaw CC; Lai GM
    Am J Clin Oncol; 1996 Aug; 19(4):337-43. PubMed ID: 8677900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-needle aspiration cytology of metastatic nasopharyngeal carcinoma.
    Jayaram G; Swain M; Khanijow V; Jalaludin MA
    Diagn Cytopathol; 1998 Sep; 19(3):168-72. PubMed ID: 9740988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
    J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiotherapy technics and results in nasopharyngeal carcinoma at the Cologne University Clinics from 1974 to 1985].
    Roth SL; Sack H; Bertram G
    Strahlenther Onkol; 1989 Sep; 165(9):633-40. PubMed ID: 2799626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance.
    Gallo O; Bianchi S; Giannini A; Gallina E; Libonati GA; Fini-Storchi O
    Laryngoscope; 1991 May; 101(5):487-93. PubMed ID: 2030628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell antigen marker expression in nasopharyngeal carcinoma.
    Zhong XY; Senba M; Gu JN; Itakura H
    Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 10-year survival rate for patient with nasopharyngeal carcinoma after radiation therapy. Clinical analysis of 367 cases.
    Chen CQ; Liu TF; Zhao S
    Chin Med J (Engl); 1989 Apr; 102(4):239-42. PubMed ID: 2507236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
    BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and evolutive aspects of nasopharyngeal T4 N0 neoplasms].
    Maalej M; Daoud J; Bouaouina N; Benna F; Frikha H; Jallouli M; Ellouze R; Ben Romdhane KB; Cammoun M; Ben Attia RB
    Bull Cancer; 1995 Sep; 82(9):728-31. PubMed ID: 8535032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma.
    Jian JJ; Cheng SH; Prosnitz LR; Tsai SY; Tsai MJ; Huang AT
    Cancer; 1998 Jan; 82(2):261-7. PubMed ID: 9445180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.